News

MUST READS

An August 9, 2016 Bloomberg article reported that “Japan’s Eisai Co. said that an Alzheimer’s drug it is developing with Massachusetts-based Biogen Inc. will enter late-stage trials after getting the green light from the U.S. Food and Drug Administration.”

USA2 SPOTLIGHT

USA2 SPOTLIGHT

MUST READS 

 

MUST READS 

Pages

^ Back to Top